Peter Frommolt

<i>PTEN</i> Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR

Martin L. Sos, Mirjam Koker, Barbara A. Weir et al. · Cancer Research · 2009 · 492 citations · Full text

Egfr-mutant Lung Cancer, Pten Loss, Cancer Biology +16

AgRP Neurons Control Systemic Insulin Sensitivity via Myostatin Expression in Brown Adipose Tissue

Sophie M. Steculorum, Johan Ruud, Ismene Karakasilioti et al. · Cell · 2016 · 288 citations · Full text

Obesity, Metabolic Syndrome, Energy Homeostasis +15

Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study

Hendrik Rosewich, Hölger Thiele, Andreas Ohlenbusch et al. · The Lancet Neurology · 2012 · 263 citations · Full text

Heterozygous De-novo Mutations, Mendelian Disorder, Genetic Disorder +7

Predicting drug susceptibility of non–small cell lung cancers based on genetic lesions

Martin L. Sos, Kathrin Michel, Thomas Zander et al. · Journal of Clinical Investigation · 2009 · 262 citations · Full text

Mutations in NNT encoding nicotinamide nucleotide transhydrogenase cause familial glucocorticoid deficiency

Eirini Meimaridou, Julia Kowalczyk, Leonardo Guasti et al. · Nature Genetics · 2012 · 260 citations · Full text

Mendelian Disorder, Genetic Disorder, Genetics +6